Last reviewed · How we verify
NCT03252730
In-Use Test With a Cosmetic Product
NA trial testing WO 4260 Cosmetic Product for Topical Use in Dermatitis, Atopic in 34 participants. Completed in 27 February 2017.
27 February 2017
Quick facts
| Lead sponsor | Dr. August Wolff GmbH & Co. KG Arzneimittel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 30 January 2017 |
| Primary completion | 27 February 2017 |
| Estimated completion | 27 February 2017 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- WO 4260 Cosmetic Product for Topical Use
Conditions studied
- Dermatitis, Atopic — all drugs for Dermatitis, Atopic →
Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Who can join
18 and older, any sex, with Dermatitis, Atopic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the tolerance of the product WO 4260 by a dermatologist. Additional objectives of this clinical in-use study are to evaluate the cosmetic features and acceptance of the product by means of a questionnaire in an interview situation and by skin hydration measurements on the scalp.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of hydrophilic or lipophilic emulsions containing <i>Echinacea purpurea</i> extract in treatment of different types of pruritus.
Kilic A, Harder A, Reich H, Knie U, et al · · 2018 · cited 4× · PMID 30538520 · DOI 10.2147/ccid.s172518
Verify or expand the search:
- PubMed search for NCT03252730
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dermatitis, Atopic
Currently open trials in the same condition.
- NCT07230860 — A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis · Phase 2 · recruiting
- NCT06899204 — Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate · recruiting
- NCT07042126 — Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis · Phase 3 · recruiting
- NCT06881251 — A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) · Phase 2 · active not recruiting
- NCT06554847 — Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis · Phase 3 · active not recruiting
Other Dr. August Wolff GmbH & Co. KG Arzneimittel trials
Trials by the same sponsor.
- NCT06244615 — Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat · NA · completed
- NCT05863104 — Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyper · Phase 2 · completed
- NCT05211505 — Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Sym · Phase 4 · completed
- NCT04222647 — Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With · Phase 2 · completed
- NCT03658616 — Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03252730 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. August Wolff GmbH & Co. KG Arzneimittel
- Last refreshed: 22 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03252730.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing